Danil
Danil compound ketoconazole solution for scalp disorders. · KETOCONAZOLE .25 mg/g; CLOBETASOL PROPIONATE 15 mg/g · Solution · Topical · Jiangsu Chenpai Bond Pharmaceutical Co.,Ltd.
NDC 84277-5665-03 · 100 g in 1 TUBE · UNAPPROVED DRUG OTHER · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- —
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- —
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Danil compound ketoconazole solution for scalp disorders. (Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Jiangsu Chenpai Bond Pharmaceutical Co.,Ltd. | KETOCONAZOLE .25 mg/g; CLOBETASOL PROPIONATE 15 mg/g | Jul 22, 2026 | Jul 29, 2026 |
| Jiangsu Chenpai Bond Pharmaceutical Co.,Ltd. | CLOBETASOL PROPIONATE .25 mg/g; KETOCONAZOLE 15 mg/g | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Danil — NDC 84277-5665-03," retrieved September 3, 2026, https://drugdashboards.com/drug/84277566503.
Free to cite with attribution — see how the data is put together.